Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04880707 · ClinicalTrials.gov registry record · Phase 2

Twin Block, Pain Medications and Third Molar Extractions

A Phase 2 study of Acute Pain, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
Phase 2
Development phase
48
Enrollment target
1
Study location

NCT04880707 is a Phase 2 study of Acute Pain that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 48 participants, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04880707, a Phase 2 study of Acute Pain, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
Phase 2
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

Each year, over 3.5 million, mostly, healthy young adults, have their third molar teeth ('wisdom teeth') removed under sedation and are often given opioid prescriptions for managing their pain. Wisdom molar removal is one of the most common reasons for opioid prescriptions to be given to adolescents. There is a national thrust to reduce both the dose and the duration of such opioid prescriptions because even short-term opioid exposures increase risk for narcotic addiction and misuse. Non-opioid options to manage pain will still allow for sufficient pain control without risking addiction, and hence, a fundamental component of our response to combat the current national opioid crisis. The investigators are going to study a promising option- the Twin Block dental anesthetic injection. The Twin block involves injecting the standard dental numbing medication in a way that 'numbs' the 'jaw-clencher' muscles on the side of the face. The investigators found that the Twin block relieved jaw pain stemming from these muscles, in a quick and sustained manner, even in patients whose pain following wisdom tooth removal primarily came from 'taut' and tender jaw-clencher muscles. However, what is not known is- how often do patients who have their wisdom teeth removed under sedation, end up in significant pain from taut and tender jaw-clencher muscles? Will using the twin block effectively reduce pain in such patients? In this pilot study, the investigators will examine wisdom molar extraction patients one day after their procedure. Those with significant pain (pain rated ≥ 5 on a 0-10 scale) in their jaw-clencher muscles, will get either the Twin block injection or a placebo. The investigators will track both 1) pain before and after the injection, and 2) pain medication usage over a 7-day period to see if both pain and opioid dosage come down with the Twin block. This study can support a simple, safe and inexpensive means to reduce pain after a common procedure.

Conditions Studied

Interventions

  • DRUG Twin block local anesthetic nerve block using standard dental anesthetic
  • OTHER Twin block with placebo

Study Locations (1)

New Jersey

  • Rutgers School of Dental Medicine - Newark

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2024-03-11
Est. Completion 2026-08
Phase Phase 2

What the Registry Record Tells You About NCT04880707

The ClinicalTrials.gov registry entry for NCT04880707 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (82% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 2 interventions - of which Twin block local anesthetic nerve block using standard dental anesthetic is the first listed.

NCT04880707 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04880707 about?

NCT04880707 is a clinical study titled "Twin Block, Pain Medications and Third Molar Extractions". Each year, over 3.5 million, mostly, healthy young adults, have their third molar teeth ('wisdom teeth') removed under sedation and are often given opioid prescriptions for managing their pain. Wisdom molar removal is one of the most common reasons for opioid prescriptions to be given to adolescents...

What is the current status of trial NCT04880707?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2024-03-11. Estimated completion is 2026-08.

What conditions does trial NCT04880707 study?

This clinical trial studies the following conditions: Acute Pain.

What interventions are being tested in trial NCT04880707?

The interventions under investigation include: Twin block local anesthetic nerve block using standard dental anesthetic (DRUG), Twin block with placebo (OTHER).

Who is sponsoring clinical trial NCT04880707?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04880707 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.